First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRx Inc. - A GSK Company
IDRx Inc. - A GSK Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virginia Commonwealth University
M.D. Anderson Cancer Center
Poniard Pharmaceuticals